MD2552G2 - Medicament in the form of suppository - Google Patents
Medicament in the form of suppositoryInfo
- Publication number
- MD2552G2 MD2552G2 MDA20040128A MD20040128A MD2552G2 MD 2552 G2 MD2552 G2 MD 2552G2 MD A20040128 A MDA20040128 A MD A20040128A MD 20040128 A MD20040128 A MD 20040128A MD 2552 G2 MD2552 G2 MD 2552G2
- Authority
- MD
- Moldova
- Prior art keywords
- suppository
- medicament
- propolis
- rectum
- vitamin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention refers to the pharmaceutical industry, in particular to the suppositories used for treatment of inflammatory processes in the rectum and urogenital system.Summary of the invention consists in that the medicament in the form of suppository contains phenolic compounds of propolis, oleic solution of vitamin E, glycerol, semisynthetic glycerides in the following component ratio, calculated for a suppository with the weight of 2,00 g:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20040128A MD2552G2 (en) | 2004-05-19 | 2004-05-19 | Medicament in the form of suppository |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20040128A MD2552G2 (en) | 2004-05-19 | 2004-05-19 | Medicament in the form of suppository |
Publications (2)
Publication Number | Publication Date |
---|---|
MD2552F1 MD2552F1 (en) | 2004-09-30 |
MD2552G2 true MD2552G2 (en) | 2005-06-30 |
Family
ID=33095718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20040128A MD2552G2 (en) | 2004-05-19 | 2004-05-19 | Medicament in the form of suppository |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2552G2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2498810C1 (en) * | 2012-05-10 | 2013-11-20 | Государственное автономное учреждение Республики Башкортостан "Центр аграрных исследований" | Antioxidant preparation with 5-aminosalicylic acid, quercetin and propolis extract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2225213C2 (en) * | 2002-03-04 | 2004-03-10 | Пятигорская государственная фармацевтическая академия | Suppository "apiprost" eliciting wound-healing effect |
-
2004
- 2004-05-19 MD MDA20040128A patent/MD2552G2/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2225213C2 (en) * | 2002-03-04 | 2004-03-10 | Пятигорская государственная фармацевтическая академия | Suppository "apiprost" eliciting wound-healing effect |
Also Published As
Publication number | Publication date |
---|---|
MD2552F1 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0717845A2 (en) | Use of compounds, pharmaceutical compositions and methods for the treatment and / or prophylaxis of diseases that can be treated with HDL-cholesterol elevating agents and compounds. | |
EP2377528A3 (en) | Fatty acid metabolism inhibitors for use in the treatment of cancer | |
MXPA06014510A (en) | Compositions and methods for treating inflammatory disorders. | |
IL158559A0 (en) | Acne treatment | |
MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
SG170826A1 (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor | |
GB9807639D0 (en) | Anti-inflammatory agents | |
NZ597489A (en) | Methods for treating conditions associated with MASP-2 dependent complement activation | |
AR054255A1 (en) | TREATMENT OF INTESTINAL DYSFUNCTION IN HIV PATIENTS | |
NZ587088A (en) | Treatment of metastatic stage prostate cancer with degarelix | |
MY172372A (en) | Compositions and methods for lowering triglycerides | |
WO2011113013A3 (en) | Methods and compositions for treating viral or virally-induced conditions | |
CL2008001626A1 (en) | Compounds derived from fused heterocycles, a pharmaceutical agent that comprises them and their use in the prophylaxis and treatment of cancer. | |
PT2040755E (en) | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity | |
DE602008005316D1 (en) | TABLETTED ATAZANA-CONTAINING COMPOSITIONS | |
NZ577393A (en) | Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction | |
CL2008003057A1 (en) | Pharmaceutical combination comprising a purine derivative and a corticosteroid, beta-2 adrenoceptor agonist, antimuscarinic agent, among others; pharmaceutical composition; and its use to treat inflammatory or obstructive airway diseases. | |
MXPA02002681A (en) | Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer. | |
DE602008005896D1 (en) | TABLETTED ATAZANA-CONTAINING COMPOSITIONS | |
MY172984A (en) | Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
PH12020551573A1 (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
PT1838716E (en) | Olanzapine pamoate dihydrate | |
EA200700353A1 (en) | ANTIMICROBANO ACTION MEANS | |
MD2552G2 (en) | Medicament in the form of suppository | |
AR074190A1 (en) | ACIDOSIS CONTROLLING AGENT FOR A RUMINANT. COMPOSITION. METHOD. I THINK. USE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |